Pilgrim develops biotechnology solutions for military organizations and defense contractors.
Pilgrim develops biotechnology solutions for military applications, focusing on warfighter capabilities and resilience in response to emerging threats and environmental challenges. Its customers include military organizations and defense contractors. In September 2026, the company raised USD 25 million in seed funding led by Buckley Ventures, with Cantos, Conviction, Mantis, Magellan, Refactor Capital, Shine Capital and Thiel Capital participating. The funding will support pathogen detection devices and an airborne disease monitoring system.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in